Position in ANAB
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,522,597
New position
Shares Held
22,557
first reported quarter
Ownership
0.078%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#79
of 211 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026BURNEY CO/ holds $24,564,619 across 12 Biotechnology names. ANAB ranks #8 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
22,078 | $5,320,135 | |
| 2 | EXEL |
Exelixis, Inc.
|
56,478 | $3,072,967 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
37,320 | $3,044,192 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
42,252 | $2,400,336 | |
| 5 | INCY |
Incyte Corp
|
20,165 | $2,285,904 | |
| 6 | RIGL |
Rigel Pharmaceuticals Inc
|
55,769 | $2,181,683 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
24,156 | $2,100,363 | |
| 8 | ANAB |
Anaptysbio, Inc
This page
|
22,557 | $1,522,597 |
All Filings in ANAB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,522,597 | 22,557 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||